UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mapping of construction materials reuse practices within large Norwegian municipalities

IOP conference series. Earth and environmental science, 2023-05, Vol.1176 (1), p.12036

2023

Volltextzugriff (PDF)

Circular economy processes in the Nordic municipal building sector – a comparison of practices and policies

IOP conference series. Earth and environmental science, 2024-06, Vol.1363 (1), p.12006

2024

Volltextzugriff (PDF)

Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota

Nature genetics, 2016-11, Vol.48 (11), p.1396-1406

2016

Volltextzugriff (PDF)

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Scientific reports, 2019-01, Vol.9 (1), p.167

2019

Volltextzugriff (PDF)

The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation

Journal of hepatology, 2017-02, Vol.66 (2), p.382-389

2017

Volltextzugriff (PDF)

Abdominal pain and symptoms before and after Roux‐en‐Y gastric bypass

BJS open, 2019-06, Vol.3 (3), p.317-326

2019

Volltextzugriff (PDF)

Health benefits and risks during 10 years after Roux-en-Y gastric bypass

Surgical endoscopy, 2020-12, Vol.34 (12), p.5368-5376

2020

Volltextzugriff (PDF)

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Scientific reports, 2024-02, Vol.14 (1), p.3704-3704, Article 3704

2024

Volltextzugriff (PDF)

Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis

Gastroenterology (New York, N.Y. 1943), 2021-04, Vol.160 (5), p.1784-1798.e0

2021

Volltextzugriff (PDF)

Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation

Mucosal immunology, 2016-11, Vol.9 (6), p.1455-1465

2016

Volltextzugriff (PDF)

Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation

Journal of hepatology, 2023-10, Vol.79 (4), p.955-966

2023

Volltextzugriff (PDF)

Associations of neopterin and kynurenine-tryptophan ratio with survival in primary sclerosing cholangitis

Scandinavian journal of gastroenterology, 2021-04, Vol.56 (4), p.443-452

2021

Volltextzugriff (PDF)

Liver abnormalities in bowel diseases

Baillière's best practice & research. Clinical gastroenterology, 2013-08, Vol.27 (4), p.531-542

2013

Volltextzugriff (PDF)

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

ESC Heart Failure, 2020-04, Vol.7 (2), p.456-466

2020

Volltextzugriff (PDF)

The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosis

Journal of hepatology, 2017, Vol.66 (1), p.S554-S555

2017

Volltextzugriff (PDF)

RETRACTED ARTICLE: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Scientific reports, 2019-01, Vol.9 (1), p.167, Article 167

2019

Volltextzugriff (PDF)

Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?

Hepatology (Baltimore, Md.), 2023-06, Vol.77 (6), p.E188-E189

2023

Volltextzugriff (PDF)

SAT-395 - The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosis

Journal of hepatology, 2017, Vol.66 (1), p.S554-S555

2017

Volltextzugriff (PDF)

P1174 : Microbiota-dependent marker trimethylamine-N-oxide (TMAO) is associated with the severity of primary sclerosing cholangitis

Journal of hepatology, 2015-04, Vol.62, p.S793-S794

2015

Volltextzugriff (PDF)

Rosuvastatin alters the genetic composition of the human gut microbiome

Scientific reports, 2020-03, Vol.10 (1), p.5397, Article 5397

2020

Volltextzugriff (PDF)

The faecal microbiome of patients with primary sclerosing cholangitis has a characteristic signature across different geographic regions

Journal of hepatology, 2018-04, Vol.68, p.S450

2018

Volltextzugriff (PDF)

FRI-200 - The faecal microbiome of patients with primary sclerosing cholangitis has a characteristic signature across different geographic regions

Journal of hepatology, 2018-04, Vol.68, p.S450-S450

2018

Volltextzugriff (PDF)

O082 : The gut microbiota in primary sclerosing cholangitis differs from that of healthy controls and ulcerative colitis patients without biliary disease

Journal of hepatology, 2015-04, Vol.62, p.S231-S232

2015

Volltextzugriff (PDF)

Chronic Abdominal Pain 5 Years After Roux-En-Y Gastric Bypass

Surgery for obesity and related diseases, 2015-11, Vol.11 (6), p.S94-S95

2015

Volltextzugriff (PDF)

Gastrointestinal symptoms 5 years after Roux-en-Y gastric bypass

Surgery for obesity and related diseases, 2015-11, Vol.11 (6), p.S163-S163

2015

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mapping of construction materials reuse practices within large Norwegian municipalities

Circular economy processes in the Nordic municipal building sector – a comparison of practices and policies

Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation

Abdominal pain and symptoms before and after Roux‐en‐Y gastric bypass

Health benefits and risks during 10 years after Roux-en-Y gastric bypass

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis

Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation

Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation

Associations of neopterin and kynurenine-tryptophan ratio with survival in primary sclerosing cholangitis

Liver abnormalities in bowel diseases

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosis

RETRACTED ARTICLE: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?

SAT-395 - The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosis

P1174 : Microbiota-dependent marker trimethylamine-N-oxide (TMAO) is associated with the severity of primary sclerosing cholangitis

Rosuvastatin alters the genetic composition of the human gut microbiome

The faecal microbiome of patients with primary sclerosing cholangitis has a characteristic signature across different geographic regions

FRI-200 - The faecal microbiome of patients with primary sclerosing cholangitis has a characteristic signature across different geographic regions

O082 : The gut microbiota in primary sclerosing cholangitis differs from that of healthy controls and ulcerative colitis patients without biliary disease

Chronic Abdominal Pain 5 Years After Roux-En-Y Gastric Bypass

Gastrointestinal symptoms 5 years after Roux-en-Y gastric bypass

Suchergebnisse filtern